SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-23-008901
Filing Date
2023-07-06
Accepted
2023-07-06 17:25:41
Documents
15
Period of Report
2023-07-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ndra_8k.htm   iXBRL 8-K 28208
2 PRESS RELEASE ndra_ex991.htm EX-99.1 13055
  Complete submission text file 0001654954-23-008901.txt   170517

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ndra-20230706.xsd EX-101.SCH 5735
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20230706_lab.xml EX-101.LAB 14667
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20230706_cal.xml EX-101.CAL 908
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20230706_pre.xml EX-101.PRE 9285
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20230706_def.xml EX-101.DEF 2109
9 EXTRACTED XBRL INSTANCE DOCUMENT ndra_8k_htm.xml XML 3603
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 231074528
SIC: 3845 Electromedical & Electrotherapeutic Apparatus